Phylogenomics of phosphoinositide lipid kinases: Perspectives on the evolution of second messenger signaling and drug discovery

BMC Evolutionary Biology

Volumn 11, Issue 1, 2011, Pages

  Brown, James R ^a   Auger, Kurt R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; ENZYME ACTIVITY; EUKARYOTE; EVOLUTIONARY BIOLOGY; GENOMICS; LIPID; MAMMAL; MEMBRANE; PHYLOGENETICS; SIGNALING;

CHORDATA; EUKARYOTA; LEISHMANIA SP.; MAMMALIA; METAZOA; PLASMODIUM FALCIPARUM; TRYPANOSOMA; TRYPANOSOMA SP.; VERTEBRATA;

PHOSPHATIDYLINOSITOL KINASE;

ANIMAL; ARTICLE; CLASSIFICATION; DRUG DEVELOPMENT; ENZYMOLOGY; EUKARYOTE; GENETICS; GENOMICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MULTIGENE FAMILY; PHYLOGENY; SECOND MESSENGER; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANIMALS; DRUG DISCOVERY; EUKARYOTA; EVOLUTION, MOLECULAR; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHYLOGENY; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 78650776871     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-11-4     Document Type: Article

References (47)

1. Phosphoinositide kinases. DA Fruman RE Meyers LC Cantley, Annu Rev Biochem 1998 67 481 507 10.1146/annurev.biochem.67.1.481 9759495
2. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. JA Engelman J Luo LC Cantley, Nat Rev Genet 2006 7 606 619 10.1038/nrg1879 16847462
3. Phosphoinositide 3-kinases: a conserved family of signal transducers. B Vanhaesebroeck SJ Leevers G Panayotou MD Waterfield, Trends Biochem Sci 1997 22 267 272 10.1016/S0968-0004(97)01061-X 9255069
4. Phosphatidylinositol 4-kinases. T Gehrmann LM Heilmeyer Jr, Eur J Biochem 1998 253 357 370 10.1046/j.1432-1327.1998.2530357.x 9654085
5. Phosphatidylinositol 4-kinases: old enzymes with emerging functions. A Balla T Balla, Trends Cell Biol 2006 16 351 361 10.1016/j.tcb.2006.05.003 16793271
6. Regulation and cellular roles of phosphoinositide 5-kinases. PA Oude Weernink M Schmidt KH Jakobs, Eur J Pharmacol 2004 500 87 99 10.1016/j.ejphar.2004.07.014 15464023
7. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. R Katso K Okkenhaug K Ahmadi S White J Timms MD Waterfield, Annu Rev Cell Dev Biol 2001 17 615 675 10.1146/annurev. cellbio.17.1.615 11687500
8. High frequency of mutations of the PIK3CA gene in human cancers. Y Samuels Z Wang A Bardelli N Silliman J Ptak S Szabo, et al. Science 2004 304 554 10.1126/science.1096502 15016963
9. Functional analysis of PIK3CA gene mutations in human colorectal cancer. T Ikenoue F Kanai Y Hikiba T Obata Y Tanaka J Imamura, et al. Cancer Res 2005 65 4562 4567 10.1158/0008-5472.CAN-04-4114 15930273
10. Drugging the PI3 kinome: from chemical tools to drugs in the clinic. P Workman PA Clarke FI Raynaud RL van Montfort, Cancer Res 2010 70 2146 2157 10.1158/0008-5472.CAN-09-4355 20179189
11. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. JA Engelman, Nat Rev Cancer 2009 9 550 562 10.1038/nrc2664 19629070
12. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'? T Ruckle MK Schwarz C Rommel, Nat Rev Drug Discov 2006 5 903 918 10.1038/nrd2145 17080027
13. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis? A Fougerat S Gayral N Malet F Briand-Mesange M Breton-Douillon M Laffargue, Clin Sci (Lond) 2009 116 791 804 10.1042/CS20080549 19397491
14. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. E Patrucco A Notte L Barberis G Selvetella A Maffei M Brancaccio, et al. Cell 2004 118 375 387 10.1016/j.cell.2004.07.017 15294162
15. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. AW Tai Y Benita LF Peng SS Kim N Sakamoto RJ Xavier, et al. Cell Host Microbe 2009 5 298 307 10.1016/j.chom.2009.02.001 19286138
16. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. NY Hsu O Ilnytska G Belov M Santiana YH Chen PM Takvorian, et al. Cell 2010 141 799 811 10.1016/j.cell.2010.03.050 20510927
17. Inositol derivatives: evolution and functions. RH Michell, Nat Rev Mol Cell Biol 2008 9 151 161 10.1038/nrm2334 18216771
18. PtdIns5P regulation through evolution: roles in membrane trafficking? O Lecompte O Poch J Laporte, Trends Biochem Sci 2008 33 453 460 10.1016/j.tibs.2008.07.002 18774718
19. Evolutionary relationships of Aurora kinases: implications for model organism studies and the development of anti-cancer drugs. JR Brown KK Koretke ML Birkeland P Sanseau DR Patrick, BMC Evol Biol 2004 4 39 10.1186/1471-2148-4- 39 15476560
20. Drugging the Plasmodium kinome: the benefits of academia-industry synergy. D Leroy C Doerig, Trends Pharmacol Sci 2008 29 241 249 10.1016/j.tips.2008.02.005 18394721
21. The TryPIKinome of five human pathogenic trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum - new tools for designing specific inhibitors. D Bahia LM Oliveira FM Lima P Oliveira JF Silveira RA Mortara, et al. Biochem Biophys Res Commun 2009 390 963 970 10.1016/j.bbrc.2009.10.086 19852933
22. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. SF Altschul TL Madden AA Schaffer J Zhang Z Zhang W Miller, et al. Nucleic Acids Res 1997 25 3389 3402 10.1093/nar/25.17.3389 9254694
23. Animals and fungi are each other's closest relatives: congruent evidence from multiple proteins. SL Baldauf JD Palmer, Proc Natl Acad Sci USA 1993 90 11558 11562 10.1073/pnas.90.24.11558 8265589
24. Mergers and acquisitions: malaria and the great chloroplast heist. GI McFadden, Genome Biol 2000 1 EVIEWS1026 10.1186/gb-2000-1-4-reviews1026 11178253
25. Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages. S Banerjee S Basu S Sarkar, BMC Genomics 2010 11 83 10.1186/1471-2164-11-83 20122178
26. A first glimpse into the pattern and scale of gene transfer in Apicomplexa. J Huang N Mullapudi T Sicheritz-Ponten JC Kissinger, Int J Parasitol 2004 34 265 274 10.1016/j.ijpara.2003.11.025 15003488
27. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. S Bamford E Dawson S Forbes J Clements R Pettett A Dogan, et al. Br J Cancer 2004 91 355 358 15188009
28. Rare cancer-specific mutations in PIK3CA show gain of function. M Gymnopoulos MA Elsliger PK Vogt, Proc Natl Acad Sci USA 2007 104 5569 5574 10.1073/pnas.0701005104 17376864
29. Patterns of somatic mutation in human cancer genomes. C Greenman P Stephens R Smith GL Dalgliesh C Hunter G Bignell, et al. Nature 2007 446 153 158 10.1038/nature05610 17344846
30. Molecular evolutionary analysis of cancer cell lines. Y Zhang MJ Italia KR Auger WS Halsey SF Van Horn GM Sathe, et al. Mol Cancer Ther 2010 9 279 291 10.1158/1535-7163.MCT-09-0508 20124449
31. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. ZA Knight B Gonzalez ME Feldman ER Zunder DD Goldenberg O Williams, et al. Cell 2006 125 733 747 10.1016/j.cell.2006.03.035 16647110
32. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. B Apsel JA Blair B Gonzalez TM Nazif ME Feldman B Aizenstein, et al. Nat Chem Biol 2008 4 691 699 10.1038/nchembio.117 18849971
33. Activity of any class IA PI3K isoform can sustain cell proliferation and survival. LC Foukas IM Berenjeno A Gray A Khwaja B Vanhaesebroeck, Proc Natl Acad Sci USA 2010 107 11381 11386 10.1073/pnas.0906461107 20534549
34. W.H.O. World malaria report. 2009 http://www.who.int/malaria/world- malaria-report-2009/en/index.html
35. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas. JC Dujardin D Gonzalez-Pacanowska SL Croft OF Olesen GF Spath, Trends Parasitol 2010 26 395 403 10.1016/j.pt.2010.04.012 20538522
36. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. V Andriantsoanirina A Ratsimbasoa C Bouchier M Jahevitra S Rabearimanana R Radrianjafy, et al. Antimicrob Agents Chemother 2009 53 4588 4597 10.1128/AAC.00610-09 19704124
37. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. VI Carrara J Zwang EA Ashley RN Price K Stepniewska M Barends, et al. PLoS ONE 2009 4 4551 10.1371/journal.pone.0004551 19234601
38. Thousands of chemical starting points for antimalarial lead identification. FJ Gamo LM Sanz J Vidal CC de E Alvarez JL Lavandera, et al. Nature 2010 465 305 310 10.1038/nature09107 20485427
39. Comparative genomics of trypanosomatid parasitic protozoa. NM El-Sayed PJ Myler G Blandin M Berriman J Crabtree G Aggarwal, et al. Science 2005 309 404 409 10.1126/science.1112181 16020724
40. Apicomplexan plastids as drug targets. GI McFadden DS Roos, Trends Microbiol 1999 7 328 333 10.1016/S0966-842X(99)01547-4 10431206
41. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 4673 4680 10.1093/nar/22.22.4673 7984417
42. PHYLIP (Phylogenetic Inference Package). [3.6]. J Felsentein, Seattle, Department of Genetics, University of Washington 2000 http://evolution.genetics. washington.edu/phylip.html
43. MRBAYES: Bayesian inference of phylogenetic trees. JP Huelsenbeck F Ronquist, Bioinformatics 2001 17 754 755 10.1093/bioinformatics/17.8.754 11524383
44. MrBayes 3: Bayesian phylogenetic inference under mixed models. F Ronquist JP Huelsenbeck, Bioinformatics 2003 19 1572 1574 10.1093/bioinformatics/btg180 12912839
45. TreeView: an application to display phylogenetic trees on personal computers. RD Page, Comput Appl Biosci 1996 12 357 358 8902363
46. The Tree of Life Web Project. DR Maddison K-S Schulz, 2007 http://tolweb.org
47. Structural insights into phosphoinositide 3-kinase catalysis and signalling. EH Walker O Perisic C Ried L Stephens RL Williams, Nature 1999 402 313 320 10.1038/46319 10580505